Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansen, S. M. Articles by Sørensen, U. B. S. Search for Related Content PubMed PubMed Citation Articles by Hansen, S. M. Articles by Sørensen, U. B. S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2003, p. 1399-1403, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1399-1403.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Method for Quantitative Detection and Presumptive Identification of Group B Streptococci on Primary Plating

Søren Mose Hansen and Uffe B. Skov Sørensen^*

Department of Medical Microbiology and Immunology, University of Aarhus, DK-8000 Aarhus C, Denmark

Received 24 July 2002/ Returned for modification 15 October 2002/ Accepted 27 November 2002

Top Abstract Introduction Materials and Methods Results Discussion References

 
Maternal prenatal screening for group B streptococci (GBS) followed by offering of intrapartum chemoprophylaxis to carriers is one of the strategies used to reduce the incidence of neonatal early-onset GBS infections. Culturing of vaginal and anorectal swab specimens in selective broth is the screening procedure recommended by the Centers for Disease Control and Prevention. This technique is sensitive; it does not, however, allow either evaluation of the degree of colonization or detection of cocolonization with several GBS clones. We have examined the carriage rate and population dynamics of GBS in a group of Danish women during pregnancy and 1 year after delivery using a new detection method. In the present paper we describe a mixed blood agar medium (MB agar) that identifies GBS in the primary cultures by detection of a double hemolysis pattern consisting of characteristic, large zones of partial hemolysis ("CAMP zones") and of narrow zones of complete hemolysis. The MB agar was at least as sensitive as culturing in selective broth for detection of GBS in vaginal and anorectal swab specimens, and GBS strains could be identified directly on the primary plate due to the CAMP zones without the need for subculturing. The carriage rate of GBS in a group of Danish women was found to be more than 30%, a figure considerably higher than the rate that was reported previously.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Streptococcus agalactiae (group B streptococcus [GBS]) is the principal cause of neonatal infections in industrialized countries. A significant decline in the prevalence of neonatal GBS infections has been observed in the United States as a result of implementation of preventive measures (7, 28). These include increased use of chemoprophylaxis during labor in women at high risk for transmitting the infection to their newborns (29). Risk-based or screening-based strategies are recommended by the Centers for Disease Control and Prevention to prevent GBS disease (6). Collection of swab specimens at 35 to 37 weeks of gestation is suggested for the screening-based approach. Rectal and vaginal swab specimens are inoculated together in a selective broth for 18 to 24 h. The broth is subcultured on sheep blood agar for another 18 to 24 h, and suspected colonies are finally examined by conventional microbiological techniques. This procedure is not applicable to semiquantitative evaluation of colonization intensity, and it is not feasible for demonstration of colonization with multiple clones.

For a longitudinal study of the rate of carriage and population dynamics of GBS in a cohort of pregnant women, we needed a medium that compensates for these shortcomings. We developed a solid medium based on a modification of the classical CAMP reaction that allows easy detection of individual colonies of GBS in primary cultures.

GBS generate a unique protein, the so-called CAMP factor, which interacts with the plasma membrane of red blood cells (RBCs) and other cell types. CAMP factor causes hemolysis of sheep RBCs (SRBCs) that have been altered by Staphylococcus aureus ß-toxin (sphingomyelinase). This phenomenon is designated the CAMP reaction, which refers to the authors Christie, Atkins, and Munch-Petersen (8). CAMP reaction-like reactions have also been observed after the combined actions of some other bacterial products on blood, and cohemolysis is therefore a more adequate expression for a hemolytic reaction induced by the synergistic actions of two different compounds, as discussed below. The CAMP factor of GBS has been characterized and has been renamed protein B. It has been suggested that the target of protein B is ceramide (N-acyl-sphingosine) (4), i.e., a membrane lipid generated from sphingomyelin by sphingomyelinase cleavage. Binding of protein B causes disorganization of the lipid bilayer of the cell membrane to an extent that results in cell lysis (4). The in vivo function of protein B has not been disclosed yet; however, the hemolytic activity seems to be an epiphenomenon (19, 27). Binding of this protein to the Fc region of immunoglobulins has been demonstrated (12, 19), and the protein seems to be lethal to rabbits and mice (30). Protein B seems to be essential for S. agalactiae, as the cfb gene encoding this protein (24) was found to be universally present in the genomes of 162 GBS strains from different geographic areas (20). Furthermore, 96 to 99% of all human GBS isolates have been found to be positive by the CAMP reaction (11, 14, 23, 25). Nearly all group A streptococci (Streptococcus pyogenes) and Streptococcus uberis strains possess equivalent genes named cfa and cfu, respectively (15, 18). The gene may also be present in some other streptococcal species (16, 18). The cohemolysis observed with other species is due to substances different from protein B. The CAMP reaction-like reaction of Listeria monocytogenes is caused by listeriolysin O (26), and that of Actinobacillus pleuropneumoniae is caused by an RTX toxin (17).

Protein B may cause lysis of ß-toxin-modified RBCs, as mentioned above; however, only cells containing more than 45 mol% of sphingomyelin in the plasma membrane are sensitive to the combined actions of the staphylococcal toxin and protein B (31). Thus, the CAMP reaction is seen on agar plates prepared from bovine RBCs and SRBCs, whereas RBCs from humans, rabbits, and guinea pigs and horse RBCs (HRBCs) are not lysed (8, 31).

We have taken advantage of the unique feature of protein B as the indicative principle in a new blood agar medium that can be used for the easy, sensitive, and specific detection and enumeration of GBS in primary cultures of complex specimens such as anorectal and vaginal swab specimens. The agar plates described in this article contained a mixture of SRBCs and HRBCs, which were made sensitive to the action of protein B by pretreatment with sphingomyelinase. The method was successfully applied in a longitudinal study of the GBS carrier status of a group of Danish women during pregnancy and after delivery (unpublished data). Compared with five other techniques for GBS detection, the new medium was found to be at least as sensitive and easier to use, since subculturing was usually unnecessary. The option for semiquantitative enumeration of GBS and detection of cocolonization with several clones of GBS is an additional advantage of the mixed blood agar (MB agar) plates.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Bacterial strains from collections. Two strains of GBS from our own collection were used for control purposes. Strain RH955 is beta-hemolytic and yields a positive CAMP reaction. Strain RH511A also yields a positive CAMP reaction but is nonhemolytic. Staphylococcal ß-toxin was prepared from cultures of an S. aureus strain (SSI AB2775) from the Department of Clinical Microbiology, Statens Serum Institut, Copenhagen, Denmark. The toxin was used for treatment of MB agar plates (see below).

Preparation of crude staphylococcal ß-toxin. Partly purified ß-toxin (sphingomyelinase) was prepared from a Todd-Hewitt broth culture (no. CM189; Oxoid Ltd., Basingstoke, United Kingdom) of the S. aureus strain as follows. The culture was incubated for 24 h at 37°C (optimum, 24 to 28 h), and the bacteria were removed by centrifugation (1,750 x g, 30 min). The clear supernatant was filter sterilized (pore size, 0.45 µm), and 104 g of (NH₄)₂SO₄ per liter was added. After the mixture was stirred with a magnetic stirrer for 1 h and allowed to settle for 30 min at room temperature, the solution was centrifuged (10,000 x g) for 20 min. The pellet of the precipitate was discharged, and another 104 g of (NH₄)₂SO₄ was added to the total volume of the supernatant. After stirring of the mixture for 1 h, the mixture was kept at room temperature. On the next day the solution was centrifuged (10,000 x g) for 20 min. The second supernatant was discharged, and the pellet of crude toxin was dissolved in 20 ml of sterile phosphate-buffered saline (PBS). The toxin concentrate was dialyzed four times against 2 liters of PBS for 24 h at 5°C. Finally, the concentrated toxin stock solution was filter sterilized (pore size, 0.45 µm) and stored at 5°C until it was used. The toxin preparation was stable for several months when stored at 5°C. The sphingomyelinase activity of the toxin stock was determined by titration. The whole surfaces of a number of MB agar plates (see below) were treated with 200 µl of twofold serial dilutions of the toxin stock in PBS. A CAMP reaction-positive strain of GBS (strain RH955) was streaked onto each of the toxin-treated plates before they were incubated overnight at 37°C. The plates were inspected for detection of two different hemolysis phenomena around colonies of GBS (double hemolysis). The action of ß-hemolysin caused narrow zones of complete hemolysis, and protein B caused larger zones of partial hemolysis (Fig. 1).

View larger version (121K): [in this window] [in a new window]

FIG. 1. Close-up photos of large CAMP zones surrounding colonies of S. agalactiae on MB agar pretreated with staphylococcal ß-toxin 1 h before they were streaked with bacteria. (A) A typical beta-hemolytic strain of GBS, strain RH955; (B) a nonhemolytic strain, strain RH511A. The plates were incubated overnight at 37°C (see text for details). Arrows: 1, bacterial colonies; 2, zones of partial hemolysis around colonies of both bacterial strains; the SRBCs are lysed in these areas due to the interaction with protein B generated by the bacteria, whereas the HRBCs are left intact, as these cells are insensitive to protein B; 3, after removal of the bacterial colony, a narrow spot of complete hemolysis, in which both kinds of RBCs are lysed due to the action of ß-hemolysin, is seen in the middle of the CAMP zone; 4, as for arrow 3, except that the bacterial colonies were left in place; beta-hemolysis is seen as thin clear rims around the bacterial colonies; 5 and 6, no beta-hemolysis appears around the colonies of strain RH511 or after removal of a colony.

The highest toxin dilution that gave optimal double hemolysis around the bacterial colonies was considered the end point. The ready-made ß-toxin solution used for pretreatment of the MB agar plates (see below) was prepared so that it was two times more concentrated than the dilution determined by end-point titration. The use of sphingomyelinase from commercial sources may be a convenient alternative to the in-house preparation of toxin. However, we have not tested such preparations.

MB agar plates. Modified CAMP reaction plates containing mixed blood were prepared with a double layer of agar. One liter of agar contained 40 g of blood agar base (no. CM854; Oxoid), 2 g of sodium pyruvate, 0.247 g of MgSO₄, and 50 mg of L-cysteine hydrochloride monohydrate. The ingredients were mixed during heating to the boiling point and then autoclaved for 15 min at 121°C. The medium was cooled and kept in a water bath at 50°C. For preparation of the top layer, 2.5% (vol/vol) packed SRBCs and 2.5% (vol/vol) packed HRBCs were added to the 50°C agar base and mixed. The blood cells were washed three times before use in PBS (0.1 M NaCl, 0.05 M phosphate buffer [pH 7.4]) and packed by centrifugation (at 500 x g for 5 min). Each plate (diameter, 9 cm) was made of a lower layer of agar base without blood cells (25 ml). After solidification, a top layer of agar base (20 ml) containing 5% mixed blood cells was added. Hemolysis is more easily seen on the relatively thin blood-containing top layer. Untreated plates were stable and could be stored for several weeks in a refrigerator. Before use, the MB agar plates were pretreated with staphylococcus ß-toxin, as described below. After treatment with the staphylococcal toxin, the plates were somewhat sensitive to lowering of the temperature. To avoid spontaneous hemolysis, these plates were kept at room temperature and used on the same day.

g-MB agar plates. MB agar plates containing gentamicin (g-MB agar plates) in both the lower and the top layers were prepared by adding 1 ml of a filter-sterilized (pore size, 0.45 µm) stock solution (4 mg per ml of H₂O) of gentamicin sulfate (658 µg of gentamicin base per mg; no. G 6896; Sigma-Aldrich, St. Louis, Mo.) per liter of agar base at 50°C (see above).

ng-MB agar plates. MB agar plates containing both nalidixic acid and gentamicin (ng-MB agar plates) in both the lower and the top layers were prepared by adding 1 ml of a filter-sterilized (pore size, 0.45 µm) stock solution (8 mg per ml of H₂O) of gentamicin sulfate (no. G 6896; Sigma-Aldrich) and 1 ml of a filter-sterilized (pore size, 0.45 µm) stock solution (15 mg per ml of 0.1 N NaOH) of nalidixic acid (no. N 8878; Sigma-Aldrich) per liter of agar base at 50°C (see above).

Pretreatment of MB agar plates with ß-toxin. A total of 200 µl of sterile ready-made ß-toxin solution (see above) was dispersed evenly with a plastic Drigalski spatula over the surface of the MB, g-MB, and ng-MB agar plates before use. The plates were kept at room temperature until the surfaces had dried (30 to 60 min).

Regular blood agar plates. Horse blood (5%) agar plates were purchased from the Statens Serum Institut.

Selective broth. Todd-Hewitt broth (no. 189; Oxoid) was supplemented with 8.0 mg of gentamicin sulfate and 15 mg of nalidixic acid per liter (6). Cotton-stoppered test tubes containing 5 ml of this medium were autoclaved for 15 min at 121°C. After the swabs were streaked on the different solid media they were placed in this selective broth, mixed carefully on a vortex mixer, and incubated overnight at 37°C. A total of 10 µl of broth from each of the test tubes was streaked on regular 5% blood agar plates, and the plates were incubated overnight at 37°C.

Bacterial identification. Suspected isolates of GBS were identified by a combination of standard tests (21). The strains were Gram stained, tested for catalase activity, and examined by the traditional CAMP test on CAMP test plates (Statens Serum Institut). The strains were examined for the presence of the group B antigen by latex agglutination (no. ZL52; Streptex; Murex Biotech Ltd., Dartford, United Kingdom).

Clinical samples. A cohort of 77 healthy women was monitored in a longitudinal study (unpublished data) from the 19th week of gestation until shortly before delivery at the Department of Obstetrics, Aarhus University Hospital, Skejby, Denmark. All pregnancies were normal, and no complications due to GBS were observed. The project was initiated in January 1999 with approval from the Ethics Committee, County of Aarhus, Denmark, and after informed consent had been provided by all volunteers. The participants were instructed in the technique for obtaining swab specimens at home. Carbon-containing cotton swabs on plastic sticks (Statens Serum Institut) were used for the sampling. Vaginal and anorectal swab specimens were obtained at different times during the pregnancy and again 1 year after delivery (spring 2001). Each swab was immediately placed in a tube containing Stuart's transport medium (Statens Serum Institut) and shipped to the laboratory by regular mail. All swabs were examined within 36 h after the samples were taken. For the present study, more than 300 paired samples were examined on up to five different media (Table 1). The swabs were inoculated on the solid media as described below for the ng-MB agar plates. Some samples were not examined on all media (exact figures are given elsewhere in the text).

View this table: [in this window] [in a new window]

TABLE 1. Frequency of GBS in swab samples cultured on different media

Evaluation of intensity of GBS colonization on ng-MB agar plates. Presumptive identification of GBS colonies is possible directly on the ng-MB agar plates (see above). These plates were therefore used for semiquantitative evaluation of the degree of colonization, as follows. Upon arrival in the laboratory in Stuart's transport medium, each swab specimen (vaginal or anorectal) was rolled and rubbed over an area 2 by 3 cm near the edge of an ng-MB agar plate. The inoculum was streaked from this area five to six times with one side of a sterile 10-µl plastic inoculation loop. To obtain well-separated colonies, spreading was continued by making three sets of streaks perpendicular to the previous streak by using the other side of the same loop. One person performed the inoculation of the agar plates to make it as reproducible as possible. Colonization intensity was evaluated semiquantitatively and blindly for each plate after incubation for 18 h at 37°C in an atmosphere containing 5% CO₂. Growth of GBS in streaking area one or two only was considered light colonization, while growth of GBS in one or more of the following streaking areas was considered moderate to heavy colonization. Samples without detectable growth of GBS were considered negative.

Reagents. All chemicals were of analytical grade and were purchased from Merck (Darmstadt, Germany) or Sigma-Aldrich.

Statistics. SigmaStat statistical software (version 1.0; Jandel Corporation, San Rafael, Calif.) was used for analysis of contingency tables by McNemar's test.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Initial experiments revealed large zones of hemolysis around colonies of GBS grown on sheep blood agar plates pretreated with staphylococcal ß-toxin. In contrast, only narrow zones of hemolysis were seen on plates not pretreated with ß-toxin. The hemolysis around colonies of GBS grown on horse blood agar plates was unaffected by ß-toxin pretreatment. On this medium the bacteria generated only narrow zones of hemolysis. A double pattern of partial and complete hemolysis was seen when the bacteria were cultured on ß-toxin-treated agar plates made with mixed SRBCs and HRBCs (MB agar; Fig. 1). The composition of the MB agar plates was optimized in a number of experiments to promote the most clear-cut reactions for GBS strains (the recipe is given in the Materials and Methods section). On this MB agar, large zones (5 to 8 mm) of partial hemolysis ("CAMP zones") and narrow zones (2 to 3 mm) of complete hemolysis (beta-hemolysis) were generated by the GBS isolates (Fig. 1A). Nonhemolytic isolates also generated a large CAMP zone (Fig. 1B), while beta-hemolytic CAMP reaction-negative isolates did not (data not shown). Experiments with S. pyogenes strains showed that the beta-hemolytic zone dominates over the CAMP zone for these strains; thus, they did not look like GBS strains.

More than 300 paired anorectal and vaginal swab samples were cultured on five different media (Table 1). GBS were easily detected on the MB agar plates by the presence of the characteristic double hemolysis around the colonies (Fig. 1A), and the sensitivity of this medium was found to be considerably higher than that of regular blood agar plates (Table 1). The nonselective plates of both media were, however, often overgrown by the commensal flora in the samples, causing a low detection rate, especially for the anorectal swab samples. Antibiotics were therefore added to the MB agar in order to improve the isolation of GBS. The best results were obtained by adding a combination of gentamicin and nalidixic acid to the agar (Table 1), even though the colonies of GBS appeared smaller on ng-MB agar medium than on medium containing gentamicin alone. The sensitivity of the selective MB agar for detection of GBS in both vaginal and anorectal swab samples was found to be at least as high as that when a selective broth was used (Table 1). Full agreement was found between the tentative diagnosis and the results of the supplementary tests when the typical double hemolysis was observed on the MB agar plates. Neither S. pyogenes nor other protein B-generating streptococci were isolated from the samples.

More than one-third of all pairs of samples were found to be positive for GBS (36.5%; 131of 358) when MB agar was used. There was a high concordance (93%) between the results obtained from the analysis of pairs of vaginal and anorectal swab specimens (Table 2; Fig. 2). No difference in the number of positive vaginal swab specimens compared to the number of positive anorectal swab specimens was seen (P = 0.31), but 5 to 10% more carriers were found when both vaginal and anorectal swab specimens were examined instead of when only one swab specimen was examined from each person. An increased rate of detection of GBS was achieved when samples were obtained from both the vaginal and the anorectal sites, as opposed to when samples were obtained from either site alone, but there was no difference in rates of detection among sampling sites. This finding has also been reported by others (22). The number of anorectal swab specimens positive for GBS was significantly higher when ng-MB agar was used for cultivation than with cultivation in selective broth (355 swab specimens were tested on these two media; of these, 91 were positive on both media, 240 were negative on both media, 21 were positive on ng-MB agar and negative in selective broth, and 3 were negative on ng-MB agar and positive in selective broth [P < 0.001]). The number of GBS-positive vaginal swab specimens detected when ng-MB agar was used for cultivation was, however, not significantly different from the number detected when selective broth was used (356 swab specimens were tested on these two media; of these, 96 were positive on both media, 245 were negative on both media, 10 were positive on ng-MB agar and negative in selective broth, and 5 were negative on ng-MB agar and positive in selective broth [P = 0.30]).

View this table: [in this window] [in a new window]

TABLE 2. Frequency of GBS in 358 pairs of anorectal and vaginal swab specimens cultured on ng-MB agar

View larger version (26K): [in this window] [in a new window]

FIG. 2. Correlation between growth densities of S. agalactiae (GBS) in 310 paired vaginal and rectal swab samples from 77 pregnant women. Vaginal samples are grouped on the abscissa according to density of growth of GBS on ng-MB agar plates. The densities of growth of GBS from the corresponding rectal swab samples were recorded as negative (open bars), slight (hatched bars), and moderate to heavy (solid bars) (see text for details).

As mentioned above, a strong correlation was found between the degree of colonization detected in the two swab samples (vaginal and anorectal) in a sample pair. For more than 90% of GBS-negative vaginal swab samples, the corresponding anorectal swab sample was negative as well (Fig. 2; Table 2). In contrast, among the GBS-positive vaginal swab samples, only 4 to 5% of the corresponding anorectal swab samples were negative. A clear tendency toward the detection of heavier colonization of the vaginal swab samples with increasing colonization of the corresponding anorectal swab samples was also seen (Fig. 2). Vaginal colonization with GBS therefore reflects the anorectal colonization density to a high degree.

Top Abstract Introduction Materials and Methods Results Discussion References

 
The CAMP test is a standard procedure for the presumptive identification of S. agalactiae (GBS) (9, 11). In the traditional assay, a ß-toxin-producing S. aureus strain is streaked across a blood agar plate made with SRBCs. A number of suspected strains of GBS are then streaked on the same plate perpendicular to the streak made with S. aureus. For most GBS strains an arrowhead-shaped hemolysis zone appears near the intersection with the S. aureus strain after incubation of the plate. This is due to the cohemolysis caused by the concerted action of ß-toxin from the S. aureus strain and protein B from the strains of GBS. While this CAMP test is useful for the presumptive identification of pure cultures of suspected strains of GBS (9), the classical assay is not applicable for direct detection of GBS in primary cultures of clinical samples. Different modifications of the CAMP test have been developed for this purpose (3, 10). However, none of these methods are optimal for routine examination of a large number of samples, since the procedures are relatively complicated. Others have used sheep blood agar plates conditioned with sterile ß-toxin-containing supernatant from an S. aureus culture for detection of CAMP test-positive GBS (1), but such agar plates cannot distinguish the CAMP reaction and ordinary ß-hemolysis.

The Centers for Disease Control and Prevention recommended a procedure for screening for carriage of GBS that requires culture of anorectal and vaginal swab specimens in a selective broth which, after incubation, is subcultured on blood agar plates; the isolates are eventually identified by serological methods (6). This procedure is specific and sensitive but is somewhat laborious, costly, and time-consuming and does not allow quantitative evaluation and proportional isolation of the individual strains in one sample.

The selective MB agar has several advantages, although preparation of the MB agar plates is more complicated than preparation of the traditional plates. Culturing on MB agar was found to be at least as sensitive as culturing in a selective broth, with a sensitivity of over 90%. The primary solid media can be inspected directly within 18 h, and reculturing is rarely needed, since typical colonies can be identified as GBS with a high degree of confidence on the basis of the characteristic hemolysis phenomenon. The density of GBS colonization can therefore be estimated semiquantitatively. We found a clear correlation between the colonization densities of GBS in paired vaginal and anorectal samples by use of ng-MB agar plates (Fig. 2). Furthermore, individual bacterial colonies can be identified on the primary plates and may be selected for further examination (e.g., for antibiotic resistance testing, DNA analysis, or serotyping).

Some bacterial species other than GBS may exhibit a positive CAMP reaction, as mentioned above, but these species do not constitute a diagnostic problem when MB agar is used for cultivation of human clinical specimens. On this medium the hemolytic pattern of group A streptococci differs from that of GBS (see above). S. ubris is not associated with humans, and in contrast to most GBS strains, strains of this species are not beta-hemolytic (21). A. pleuropneumoniae is found only in pigs. Occasionally, stool samples may contain L. monocytogenes (2), and colonies of this species resemble colonies of beta-hemolytic streptococci on blood agar. However, L. monocytogenes is sensitive to gentamicin and will, therefore, not appear on the selective MB agar plates. Furthermore, differentiation from GBS is easily accomplished by demonstrating the positive catalase reaction of L. monocytogenes.

Among a group of 77 pregnant women, we found 21% to be persistent carriers of GBS and an additional 27% to be transient carriers of GBS. These rates are considerably higher than the rates previously reported for a large group of Danish pregnant women (13), in which only 8 to 15% carriers of GBS were found. Other recent rates of carriage are not available from Denmark. Our prevalence findings based on the use of selective MB agar are similar to those recently reported for younger women from the United States. In a prevalence study in which the selective broth technique was used, 34% of female university students were found to be colonized with GBS (5), and among a group of pregnant women in a prospective cohort study, 28% were found to be colonized with GBS (22).

 
This work was supported by grant 9900316 kg/mp from the Danish Medical Research Agency.

 
* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, Bartholin Building, University of Aarhus, DK-8000 Aarhus C, Denmark. Phone: 45 89421740. Fax: 45 86196128. E-mail: uss{at}microbiology.au.dk.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Anthony, B. C., D. M. Okada, and C. J. Hobel. 1978. Epidemiology of group B streptococci: longitudinal observations during pregnancy. J. Infect. Dis. 137:524-530.[Medline]
2
2. Armstrong, D. 1995. Listeisteria monocytogenes, p. 1880-1885. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas and Bennett's principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y.
3
3. Bae, B. H., and E. J. Bottone. 1980. Modified Christie-Atkins-Munch-Petersen (CAMP) test for direct identification of hemolytic and non-hemolytic group B streptococci on primary plating. Can. J. Microbiol. 26:539-542.[Medline]
4
4. Bernheimer, A. W., R. Linder, and L. S. Avigad. 1979. Nature and mechanism of action of the CAMP protein of group B streptococci. Infect. Immun. 23:838-844.[Abstract/Free Full Text]
5
5. Bliss, S. J., S. D. Manning, P. Tallman, C. J. Baker, M. D. Pearlman, C. F. Marrs, and B. Foxmann. 2002. Group B Streptococcus colonization in male and non-pregnant female university students: a cross-sectional prevalence study. Clin. Infect. Dis. 34:184-190.[CrossRef][Medline]
6
6. Centers for Disease Control and Prevention. 1996. Prevention of perinatal group B streptococcal disease: a public health perspective. Morb. Mortal. Wkly. Rep. 45:1-24.[Medline]
7
7. Centers for Disease Control and Prevention. 2000. Early-onset group B streptococcal disease—United States, 1998-1999. Morb. Mortal. Wkly. Rep. 49:793-796.
8
8. Christie, R., E. Atkins, and E. Munch-Petersen. 1944. A note on a lytic phenomenon shown by group B streptococci. Aust. J. Exp. Biol. Med. Sci. 22:197-200.[CrossRef]
9
9. Darling, C. L. 1975. Standardization and evaluation of the CAMP reaction for the prompt, presumptive identification of Streptococcus agalactiae (Lancefield group B) in clinical material. J. Clin. Microbiol. 1:171-174.[Abstract/Free Full Text]
10
10. DiPersio, J. R., J. E. Barrett, and R. L. Kaplan. 1985. Evaluation of the Spot-CAMP test for the rapid presumptive identification of group B streptococci. Am. J. Clin. Pathol. 84:216-219.[Medline]
11
11. Facklam, R. R., J. F. Padula, E. C. Worthham, R. C. Cooksey, and H. A. Rountree. 1979. Presumptive identification of group A, B, and D streptococci on agar plate media. J. Clin. Microbiol. 9:665-673.[Abstract/Free Full Text]
12
12. Fehrenbach, F. J., D. Jurgens, J. Ruhlmann, B. Sterzik, and M. Özel. 1988. Role of CAMP-factor (protein B) for virulence. Zentbl. Bakteriol. Parasitenkd. Infektkrankh. Hyg. Abt. 1 Orig. Suppl. 17:351-357.
13
13. Feikin, D. R., P. Thorsen, S. Zywicki, M. Arpi, J. G. Westergaard, and A. Schuchat. 2001. Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women. Am. J. Obstet. Gynecol. 184:427-433.[CrossRef][Medline]
14
14. Fuchs, P. C., C. Christy, and R. N. Jones. 1978. Multiple-inocula (replicator) CAMP test for presumptive identification of group B streptococci. J. Clin. Microbiol. 7:232-233.[Abstract/Free Full Text]
15
15. Gase, K., J. J. Ferretti, C. Primeaux, and W. M. McShan. 1999. Identification, cloning, and expression of the CAMP factor gene (cfa) of group A streptococci. Infect. Immun. 67:4725-4731.[Abstract/Free Full Text]
16
16. Hassan, A. A., A. Abdulmawjood, A. O. Yildirim, K. Fink, C. Lammler, and R. Schlenstedt. 2000. Identification of streptococci isolated from various sources by determination of cfb gene and other CAMP-factor genes. Can. J. Microbiol. 46:946-951.[CrossRef][Medline]
17
17. Jansen, R., J. Briaire, E. M. Kamp, A.L. Gielkens, and M. A. Smits. 1995. The CAMP effect of Actinobacillus pleuropneumoniae is caused by Apx toxins. FEMS Microbiol. Lett. 126:139-143.[CrossRef][Medline]
18
18. Jiang, M., L. A. Babiuk, and A. A. Potter. 1996. Cloning, sequencing and expression of the CAMP factor gene of Streptococcus uberis. Microb. Pathog. 20:297-307.[CrossRef][Medline]
19
19. Jurgens, D., B. Sterzik, and F. J. Fehrenbach. 1987. Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity. J. Exp. Med. 165:720-732.[Abstract/Free Full Text]
20
20. Ke, D., C. Menard, F. J. Picard, M. Boissinot, M. Ouellette, P. H. Roy, and M. G. Bergeron. 2000. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin. Chem. 46:324-331.[Abstract/Free Full Text]
21
21. Kilian, M. 1998. Streptococcus and Lactobacillus, p. 633-667. In A. Balows and B. I. Duerden (ed.), Topley and Wilson's microbiology and microbial infections, 9th ed. Arnold, London, United Kingdom.
22
22. Orafu, C., P. Gill, C. Nelson, B. Hecht, and M. Hopkins. 2002. Perianal versus anorectal specimens: is there a difference in group B streptococcal detection? Obstet. Gynecol. 99:1036-1039.[CrossRef][Medline]
23
23. Phillips, E. A., J. W. Tapsall, and D. D. Smith. 1980. Rapid tube CAMP test for identification of Streptococcus agalactiae (Lancefield group B). J. Clin. Microbiol. 12:135-137.[Abstract/Free Full Text]
24
24. Podbielski, A., O. Blankenstein, and R. Lutticken. 1994. Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor. Med. Microbiol. Immunol. 183:239-256.[CrossRef][Medline]
25
25. Ratner, H. B., S. W. Lyndell, and C. W. Stratton. 1986. Evaluation of spot CAMP test for identification of group B streptococci. J. Clin. Microbiol. 24:296-297.[Abstract/Free Full Text]
26
26. Ripio, M. T., C. Geoffroy, G. Dominguez, J. E. Alouf, and J. A. Vazquez-Boland. 1995. The sulphydryl-activated cytolysin and a sphingomyelinase C are the major membrane-damaging factors involved in cooperative (CAMP-like) haemolysis of Listeria spp. Res. Microbiol. 146:303-313.[Medline]
27
27. Ruhlmann, J., B. Wittmann-Liebold, D. Jurgens, and F. J. Fehrenbach. 1988. Complete amino acid sequence of protein B. FEBS Lett. 235:262-266.[CrossRef][Medline]
28
28. Scharg, S. J., S. Zywicki, and M. M. Farley. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342:15-20.[Abstract/Free Full Text]
29
29. Schuchat, A. 2000. Neonatal group B streptococcal disease—screening and prevention. N. Engl. J. Med. 343:209-210.
30
30. Skalka, B., and J. Smola. 1981. Lethal effect of CAMP-factor and uberis-factor: a new finding about diffusible exosubstances of Streptococcus agalactiae and Streptococcus uberis. Zentbl. Bakteriol. Parasitenkd. Infektkrankh. Hyg. Abt. 1 Orig. Reihe A 249:190-194.
31
31. Sterzik, B., and F. J. Fehrenbach. 1985. Reaction components influencing CAMP factor induced lysis. J. Gen. Microbiol. 131:817-820.[Abstract/Free Full Text]

---

Journal of Clinical Microbiology, April 2003, p. 1399-1403, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1399-1403.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Busetti, M., D'Agaro, P., Campello, C. (2007). Group B streptococcus prevalence in pregnant women from North-Eastern Italy: advantages of a screening strategy based on direct plating plus broth enrichment. J. Clin. Pathol. 60: 1140-1143 [Abstract] [Full Text]  
• Hansen, S. M., Uldbjerg, N., Kilian, M., Sorensen, U. B. S. (2004). Dynamics of Streptococcus agalactiae Colonization in Women during and after Pregnancy and in Their Infants. J. Clin. Microbiol. 42: 83-89 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansen, S. M. Articles by Sørensen, U. B. S. Search for Related Content PubMed PubMed Citation Articles by Hansen, S. M. Articles by Sørensen, U. B. S.